Medtronic plc (LON:0Y6X)
London · Delayed Price · Currency is GBP · Price in USD | Market Cap | 89.82B |
| Revenue (ttm) | 25.45B |
| Net Income (ttm) | 3.47B |
| Shares Out | n/a |
| EPS (ttm) | 2.69 |
| PE Ratio | 25.90 |
| Forward PE | 16.08 |
| Dividend | 2.14 (2.39%) |
| Ex-Dividend Date | Sep 26, 2025 |
| Volume | 2,663 |
| Average Volume | 9,262 |
| Open | 90.49 |
| Previous Close | 90.33 |
| Day's Range | 90.44 - 92.08 |
| 52-Week Range | 79.31 - 100.00 |
| Beta | 0.74 |
| RSI | 44.37 |
| Earnings Date | Nov 18, 2025 |
About Medtronic
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair produc... [Read more]
Financial Performance
In 2025, Medtronic's revenue was $33.54 billion, an increase of 3.62% compared to the previous year's $32.36 billion. Earnings were $4.66 billion, an increase of 26.82%.
Financial numbers in USD Financial StatementsNews
Medtronic (MDT) Laps the Stock Market: Here's Why
Medtronic (MDT) closed the most recent trading day at $92.2, moving +2.38% from the previous trading session.
See Which Of The Latest 13F Filers Holds MDT
At Holdings Channel, we have reviewed the latest batch of the 34 most recent 13F filings for the 09/30/2025 reporting period, and noticed that Medtronic PLC (Symbol: MDT) was held by 17 of these funds...
Medtronic to announce financial results for its second quarter of fiscal year 2026
GALWAY, Ireland , Nov. 5, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that it will report financial results on Tuesday, November 18, 2025,...
Medtronic Enters Oversold Territory
The DividendRank formula at Dividend Channel ranks a coverage universe of thousands of dividend stocks, according to a proprietary formula designed to identify those stocks that combine two important ...
Medtronic (MDT) Announces Executive Vice President Gregory L. Smith's Retirement
Medtronic (MDT) Announces Executive Vice President Gregory L. Smith's Retirement
Orchestra BioMed to Host Business Update Call on November 12, 2025
NEW HOPE, Pa., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) (“Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to pat...
Best Dividend Aristocrats For November 2025
The ProShares S&P 500 Dividend Aristocrats ETF (NOBL) has underperformed SPY in 2025, with a 6.27% YTD gain versus SPY's 17.8%. Despite overall underperformance, select Aristocrats like CAT, CAH, CHRW...
December 2026 Options Now Available For Medtronic (MDT)
Investors in Medtronic PLC (Symbol: MDT) saw new options begin trading today, for the December 2026 expiration. One of the key data points that goes into the price an option buyer is willing to pay, i...
Medtronic (MDT) Gains CMS Approval for Innovative Blood Pressure Treatment
Medtronic (MDT) Gains CMS Approval for Innovative Blood Pressure Treatment
U.S. Centers for Medicare & Medicaid Services finalizes National Coverage Determination for the Medtronic Symplicity Spyral™ renal denervation (RDN) system
Symplicity blood pressure procedure is now covered for qualifying Medicare patients GALWAY, Ireland , Oct. 28, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology,...
Intuitive Surgical vs. Medtronic: Which Stock Is the Better Buy?
The long-awaited face-off between these two medical device giants is finally upon us.
Medtronic (MDT) Reveals Promising Long-Term Blood Pressure Reduction Results
Medtronic (MDT) Reveals Promising Long-Term Blood Pressure Reduction Results
Medtronic's RDN Procedure Shows Lasting Blood Pressure Reductions In 3-Year SPYRAL HTN-ON MED Trial
(RTTNews) - Medtronic plc (MDT) announced compelling long-term data from the final report of its SPYRAL HTN-ON MED randomized clinical trial. The results demonstrated that patients treated with the Sy...
Three-year SPYRAL HTN-ON MED results show sustained, 18 mmHg office-based blood pressure reductions
Long-term data shows significant and sustained blood pressure reductions in both office-based and 24-hour ambulatory blood pressure, reinforcing the durability, safety and effectiveness of the Symplic...
Medtronic: A Revitalized Dividend Aristocrat To Buy Now
Medtronic's shares have sharply rallied over the last six months. The medtech giant's growth catalysts include a best-in-class product (Affera) in a fast-growing $11 billion space and a massive opport...
Medtronic (MDT) Maintains Positive Outlook Despite CAS Concerns
Medtronic (MDT) Maintains Positive Outlook Despite CAS Concerns
Guru Fundamental Report for MDT
Below is Validea's guru fundamental report for MEDTRONIC PLC (MDT). Of the 22 guru strategies we follow, MDT rates highest using our Multi-Factor Investor model based on the published strategy of Pim ...
Medtronic (MDT) Announces Key Amendments and Approvals at 2025 Annual General Meeting
Medtronic (MDT) Announces Key Amendments and Approvals at 2025 Annual General Meeting
It's time to scoop up undervalued stocks in this critical sector of the economy
Expanding your horizons and considering neglected sectors can help you identify bargain opportunities while defending your investment portfolio from a stock-market decline.
Validea Detailed Fundamental Analysis - MDT
Below is Validea's guru fundamental report for MEDTRONIC PLC (MDT). Of the 22 guru strategies we follow, MDT rates highest using our Multi-Factor Investor model based on the published strategy of Pim ...
Truist Securities Raises Medtronic (MDT) Price Target to $103 | MDT Stock News
Truist Securities Raises Medtronic (MDT) Price Target to $103 | MDT Stock News
Why Medtronic (MDT) is a Top Momentum Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Why Medtronic (MDT) is a Top Value Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Medtronic Stock's $50 Billion Gift To Investors
In the last decade, Medtronic (MDT) stock has returned a notable $52 Bil back to its shareholders through cold, hard cash via dividends and buybacks. Let's look at some numbers and compare how this pa...